387 related articles for article (PubMed ID: 27565564)
21. An antibody to the aggregated synthetic prion protein peptide (PrP106-126) selectively recognizes disease-associated prion protein (PrP) from human brain specimens.
Jones M; Wight D; McLoughlin V; Norrby K; Ironside JW; Connolly JG; Farquhar CF; MacGregor IR; Head MW
Brain Pathol; 2009 Apr; 19(2):293-302. PubMed ID: 18507665
[TBL] [Abstract][Full Text] [Related]
22. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
23. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
24. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells.
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
PLoS One; 2014; 9(9):e106516. PubMed ID: 25181483
[TBL] [Abstract][Full Text] [Related]
26. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
[TBL] [Abstract][Full Text] [Related]
27. Novel method for classification of prion diseases by detecting PrP
Koyama S; Yagita K; Hamasaki H; Noguchi H; Shijo M; Matsuzono K; Takase KI; Kai K; Aishima SI; Itoh K; Ninomiya T; Sasagasako N; Honda H
Prion; 2024 Dec; 18(1):40-53. PubMed ID: 38627365
[TBL] [Abstract][Full Text] [Related]
28. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation.
Kim CL; Karino A; Ishiguro N; Shinagawa M; Sato M; Horiuchi M
J Gen Virol; 2004 Nov; 85(Pt 11):3473-3482. PubMed ID: 15483265
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to a nonconjugated prion protein peptide 95-123 interfere with PrP( Sc ) propagation in prion-infected cells.
Oboznaya MB; Gilch S; Titova MA; Koroev DO; Volkova TD; Volpina OM; Schätzl HM
Cell Mol Neurobiol; 2007 May; 27(3):271-84. PubMed ID: 17205391
[TBL] [Abstract][Full Text] [Related]
30. Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Pankiewicz J; Prelli F; Sy MS; Kascsak RJ; Kascsak RB; Spinner DS; Carp RI; Meeker HC; Sadowski M; Wisniewski T
Eur J Neurosci; 2006 May; 23(10):2635-47. PubMed ID: 16817866
[TBL] [Abstract][Full Text] [Related]
31. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
32. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP.
Yamasaki T; Suzuki A; Shimizu T; Watarai M; Hasebe R; Horiuchi M
J Gen Virol; 2012 Mar; 93(Pt 3):668-680. PubMed ID: 22090211
[TBL] [Abstract][Full Text] [Related]
33. Counting of single prion particles bound to a capture-antibody surface (surface-FIDA).
Birkmann E; Henke F; Weinmann N; Dumpitak C; Groschup M; Funke A; Willbold D; Riesner D
Vet Microbiol; 2007 Aug; 123(4):294-304. PubMed ID: 17499942
[TBL] [Abstract][Full Text] [Related]
34. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
[TBL] [Abstract][Full Text] [Related]
35. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP.
Yuan FF; Biffin S; Brazier MW; Suarez M; Cappai R; Hill AF; Collins SJ; Sullivan JS; Middleton D; Multhaup G; Geczy AF; Masters CL
Immunol Cell Biol; 2005 Dec; 83(6):632-7. PubMed ID: 16266315
[TBL] [Abstract][Full Text] [Related]
36. The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.
Shindoh R; Kim CL; Song CH; Hasebe R; Horiuchi M
J Virol; 2009 Apr; 83(8):3852-60. PubMed ID: 19176630
[TBL] [Abstract][Full Text] [Related]
37. N(ε)-Carboxymethyl Modification of Lysine Residues in Pathogenic Prion Isoforms.
Choi YG; Shin HY; Kim JI; Choi EK; Carp RI; Kim YS
Mol Neurobiol; 2016 Jul; 53(5):3102-3112. PubMed ID: 25983034
[TBL] [Abstract][Full Text] [Related]
38. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
Vorberg I; Chan K; Priola SA
J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
[TBL] [Abstract][Full Text] [Related]
39. [Establishment of a protein misfolding cyclic amplification for PrPSc].
Han J; Han L; Shi Q; Shi S; Wang X; Zhang BY; Dong XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):202-4. PubMed ID: 17971920
[TBL] [Abstract][Full Text] [Related]
40. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
